Human germ cell tumours: Expression of γ-glutamyl transpeptidase and sensitivity to cisplatin

British Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 75-79

  Hanigan, M H ^a,c   Frierson Jr , H F ^a   Abeler, V M ^b   Kaern, J ^b   Taylor Jr , P T ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Chemotherapy; Glutathione; Human tumours; Platinum based therapy

Indexed keywords

CISPLATIN; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG SENSITIVITY; DYSGERMINOMA; EMBRYONAL CARCINOMA; ENZYME ACTIVITY; FEMALE; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SEMINOMA; YOLK SAC TUMOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ENDODERMAL SINUS TUMOR; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GERMINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; TESTICULAR NEOPLASMS;

EID: 0032867954     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690653     Document Type: Article

References (21)

1. American Joint Committee on Cancer (1997) AJCC Cancer Staging Manual, 5th Ed. Lippincott-Raven; Philadelphia
2. Bailey HH, Gipp JJ and Mulcahy RT (1994) Increased expression of gamma glutamyl transpeptidase in transfected tumor cells and its relationship to drug sensitivity. Cancer Lett 87: 163-170
3. Chu G (1994) Cellular responses to cisplatin. J Biol Chem 269: 787-790
4. Dekant W, Vamvakas S and Anders MW (1995) Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: cysteine conjugate beta-lyase pathway. In: Advances in Pharmacology, Vol. 27. Anders MW and Dekant W (eds), pp. 115-162. Academic Press; New York
5. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777-1781
6. FIGO (1988) Annual Report of the Results of Treatment in Gynecological Cancer, Vol. 20. International Federation of Gynecology and Obstetrics: Stockholm
7. FIGO (1989) Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet 28: 189-193
8. Glantz SA (1992) Primer of Bio-Statics, 3rd edn. McGraw Hill: New York
9. Godwin AK, Meister A, O'Dwyer PJ, Huang CS, Hamilton TC and Anderson ME (1992) High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci USA 89: 3070-3074
10. Hanigan MH and Ricketts WA (1993) Extracellular glutathione is a source of cysteine for cells that express gamma glutamyl transpeptidase. Biochemistry 32: 6302-6306
11. Hanigan MH, Frierson HF Jr, Brown JE, Lovell MA and Taylor PT (1994a) Human ovarian tumors express gamma-glutamyl transpeptidase. Cancer Res 54: 286-290
12. Hanigan MH, Gallagher BC, Taylor PT Jr and Large MK (1994b) Inhibition of gamma-glutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatin-induced toxicity. Cancer Res 54: 5925-5929
13. Hanigan MH (1995) Expression of gamma-glutamyl transpeptidase provides tumor cells with a selective growth advantage at physiologic concentrations of cyst(e)ine. Carcinogeneis 16: 181-185
14. Hanigan MH and Frierson HF Jr (1996) Immunohistochemical detection of γ-glutamyl transpeptidase in normal human tissue. J Histochem Cytochem 44: 1101-1108
15. Hanigan MH, Frierson HF Jr and Taylor PT Jr (1998) Expression of gamma-glutamyl transpeptidase in stage III and IV ovarian surface epithelial carcinomas does not alter response to primary cisplatin-based chemotherapy. Am J Obstet Gynecol 179: 363-367
16. Hochwald SN, Harrison LE, Rose DM, Anderson M and Burt ME (1996) Gamma-glutamyl transpeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 88: 193-197
17. Miller AB, Hoogstraten B, Staquet M and Winkler A (1981) Reporting results of cancer treatment. Cancer 47: 207-214
18. Segelov E, Campbell J, Ng M, Tattersall M, Rome R, Free K, Hacker N and Friedlander ML (1994) Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12: 378-384
19. Sepulveda AR, Habib GM, Damjanov A, Matacic S, Damjanov I, Lebovitz RM and Lieberman MW (1995) Expression of gamma-glutamyl transpeptidase in midgestational mouse yolk sac and mouse visceral yolk sac carcinoma cells. Exp Cell Res 219: 494-498
20. Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB and Schmidt DE Jr (1996) Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 50: 149-159
21. Van T Sant P, Sleijfer DT, Schraffordt Koops H, Suurmeijer AJH, Willemse PHB, De Bruijn HWA, Marrink J and Ockhiuzen T (1984) The pattern of γ-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase inpatients with disseminated non-seminomatous testicular tumors. Eur J Cancer Clin Oncol 20: 209-215